24 June 2014
Limitless Earth plc's
(the "Company" or "LME")
Trading Update
Following the successful Admission to AIM of the Company's shares in May 2014,
the Board of LME is pleased to provide shareholders with a trading update.
The Company has initiated preliminary due diligence on several prospective
investment opportunities in line with its stated investing policy of acquiring
businesses in sectors that benefit from demographic change. The quality and
range of these and other opportunities being brought to the Company, coupled
with further market analysis undertaken since Admission, has identified
opportunities arising from ageing populations, less healthy lifestyles, and the
on-going boom in population numbers which is putting enormous pressure on
global health. The Board will therefore initially focus on the "Health &
Wellness" sector, within its strategy of demographic trend investing.
As outlined above, LME is in discussions with several companies that have
products that fit with the trending demand profile in the Health & Wellness
sector and it will update the market with its progress in due course.
As of 20 June 2014, the Company holds cash equivalent to 4.6 pence a
share. Given this strong cash position, the Board expects any investments or
acquisitions in the foreseeable future not to require any further capital
raising, with any cash requirement being sourced from existing funds.
For further information please contact:
Limitless Earth plc www.limitlessearthplc.com
Dominic White +44 7972 000 093
Cairn Financial Advisers LLP +44 20 7148 7900
Nominated Adviser www.cairnfin.com
Jo Turner/Liam Murray
Global Investment Strategy Limited +44 20 7048 9400
Joint Broker www.gisukltd.com
John Gunn
Peterhouse Corporate Finance Limited +44 20 7469 0930
Joint Broker www.pcorpfin.com
Peter Greensmith
Notes to Editors:
Background on Health & Wellness sector
In March 2014, Accenture, a leading management consulting company, reports that
the $502 billion consumer healthcare market is expected to grow by nearly 50
per cent. to $737 billion over the next five years. The growth is primarily
driven by preventive Health & Wellness sector sub-categories such as vitamins,
minerals & supplements ("VMS"), nutrition, weight management and fortified
foods & beverages and spurred on by demand from digitally-enabled, health
conscious consumers and the growing wealth of emerging market consumers.
Accenture estimates that less than 15 per cent. of this growth is likely to
come from `Over The Counter' products (pain, cough/cold/stomach remedies),
where the historical market leaders are positioned today. It is believed that
the remaining 85 per cent. of the growth will come from categories, such as
VMS, nutrition, fortified foods & beverages.
Changing consumer behaviours spurred on by demographics, evolving healthcare
policies and the digital revolution, were assessed to be driving growth due to
the following:
* Empowered with increasing information and personal technology, the
digitally enabled consumer wants to be a stakeholder in their own health
and wellness;
* In emerging markets, consumer affluence is growing as the population ages.
China is expected to have 331m people aged 65 or older by 2050 more than
the entire US population today;
* Sedentary lifestyles can be tied to rising levels of chronic diseases. One
in two adults are overweight or obese in the US; and
* Consumers are realising they have to take a more active role in managing
their health as the industry moves towards improved health through illness
prevention rather than cure, and governments and employers are
incentivising healthier lifestyles.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.